SAVA Cassava Sciences, Inc.

Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs.

$48.48  +4.53 (10.31%)
As of 09/17/2021 15:59:55 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/11/2000
Outstanding shares:  40,014,695
Average volume:  12,514,353
Market cap:   $1,758,645,845
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14817C107
ISIN:        US14817C1071
Sedol:      BJVLKZ9

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%